3Swanson SJ, Sugarhaker DJ. The three-bole esophagectomy. The Brigham and Women: Hospital approach ( modified McKeown tech- nique). Chest Surg Clin N Am,2000,10:531-552.
4van der Slnis PC, Ruurda JP, van der Horst S, et al. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open for resectable esophageal cancer, a ran- domized controlled trial ( ROBOT trial). Trials,2012,13:230.
5Lagarde SM, Omloo JM, Ubbink DT, et al. Predictive factors associ- ated with prolonged chest drain production after esophageetomy. Dis Esophagus ,2007,20:24-28.
6Pham TH, Perry KA, Dolan J-P, et al. Comparison of perioperative and open Ivor-Lewis esophageetomy. Am J Surg, 2010, 199:594- 598.
7Karl RC, Sehreiber R, Boulware D, et al. Factors affec:fing morbidi- ty, mortality,and survival in patients undergoing Ivor-Lewis esopha- gogastreetomy. Ann Surg,2000,231:635-643.
8Ferguson MK, Durkin AE. Preoperative prediction of the risk of pul- monary complications after esophageetomy for cancer. J Thorae Card- iovase Surg, 2002,123:661-669.
9Neoral C, Horakova M, Aujesky R, et al. Infectious complications after esophagectomy. Surg Infect (I_archmt) ,2012,13:159-162.
10Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital mor- bidity and mortality following esophagectomy. Ann Thorac Surg, 2004,78 : 1170-1176.
